Yihua Pei
Yihua Pei
Verified email at
Cited by
Cited by
Drug delivery to macrophages: challenges and opportunities
Y Pei, Y Yeo
Journal of Controlled Release 240, 202-211, 2016
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
J Park, J Park, Y Pei, J Xu, Y Yeo
Advanced drug delivery reviews 104, 93-109, 2016
Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages
Y Pei, MF Mohamed, MN Seleem, Y Yeo
Journal of Controlled Release 267, 133-143, 2017
Surface modification of polymeric nanoparticles with M2pep peptide for drug delivery to tumor-associated macrophages
L Pang, Y Pei, G Uzunalli, H Hyun, LT Lyle, Y Yeo
Pharmaceutical research 36, 1-12, 2019
Antibacterial nanotruffles for treatment of intracellular bacterial infection
MG Elnaggar, K Jiang, HE Eldesouky, Y Pei, J Park, SA Yuk, F Meng, ...
Biomaterials 262, 120344, 2020
Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging
J Park, Y Pei, H Hyun, MA Castanares, DS Collins, Y Yeo
Journal of Controlled Release 268, 407-415, 2017
Tigliane diterpene esters with IFN γ-inducing activity from the leaves of Aleurites fordii
YH Pei, JW Kim, HB Kang, HK Lee, CS Kim, HH Song, YW Chin, SR Oh
Bioorganic & medicinal chemistry letters 22 (6), 2318-2320, 2012
Selective estrogen receptor modulation by Larrea nitida on MCF-7 cell proliferation and immature rat uterus
HN Ahn, SY Jeong, GU Bae, M Chang, D Zhang, X Liu, Y Pei, YW Chin, ...
Biomolecules & therapeutics 22 (4), 347, 2014
Topical application of zwitterionic chitosan suppresses neutrophil-mediated acute skin inflammation
SW Lee, HJ Park, Y Pei, Y Yeo, S Hong
International journal of biological macromolecules 158, 1184-1193, 2020
Triterpenes with cytotoxicity from the leaves of Vernicia fordii
YH Pei, OK Kwon, JS Lee, HJ Cha, KS Ahn, SR Oh, HK Lee, YW Chin
Chemical and Pharmaceutical Bulletin 61 (6), 674-677, 2013
Synthesis and bioactivity of readily hydrolysable novel cationic lipids for potential lung delivery application of mRNAs
Y Pei, Y Bao, C Sacchetti, J Brady, K Gillard, H Yu, S Roberts, K Rajappan, ...
Chemistry and physics of lipids 243, 105178, 2022
Spiroketones and a Biphenyl Analog from Stems and Leaves of Larrea nitida and Their Inhibitory Activity against IL-6 Production
J Ahn, Y Pei, HS Chae, SH Kim, YM Kim, YH Choi, J Lee, M Chang, ...
Molecules 23 (2), 302, 2018
Development of poly (lactide-co-glycolide) microparticles for sustained delivery of meloxicam
Y Pei, J Wang, NU Khaliq, F Meng, KA Oucherif, J Xue, SD Horava, ...
Journal of Controlled Release 353, 823-831, 2023
Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis
CG Perez-Garcia, K Tachikawa, D Matsuda, P Chivukula, PP Karmali, ...
US Patent App. 18/052,505, 2023
WS16. 03 LUNAR-CF: an mRNA replacement approach for cystic fibrosis lung disease
D Geller, CG Perez-Garcia, Y Pei, X Liu, J Engelhardt, C Hodges, ...
Journal of Cystic Fibrosis 21, S31, 2022
663: LUNAR efficiently delivers mRNA into ferret airway epithelial cells in vitro and in vivo
X Liu, M Luo, Y Pei, B Bao, Q Cai, B Liang, D Bartels, C Perez-Garcia, ...
Journal of Cystic Fibrosis 20, S314-S315, 2021
LUNAR®-CF, A Novel mRNA Therapeutic Approach to Correct the Root Cause of Cystic Fibrosis Lung Disease
CG Perez-Garcia, Y Pei, Y Bao, P Karmali, X Liu, J Engelhardt, C Hodges, ...
LUNAR®-CF, an aerosolized mRNA replacement Therapy for Cystic Fibrosis Lung Disease
CG Perez-Garcia, Y Pei, Y Bao, P Karmali, J Engelhardt, X Liu, C Hodges, ...
Particle Engineering for Intracellular Delivery of Antibiotics
Y Pei
Purdue University, 2018
Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
SR Oh, JW Kim, YH Pei, HK Lee, HB Kang, DY Kim, KS Ahn
US Patent 9,174,925, 2015
The system can't perform the operation now. Try again later.
Articles 1–20